Celltrion today announced that Health Canada has approved Omlyclo™, a biosimilar referencing Xolair®. Omlyclo™ is approved ...

Celltrion's asthma treatment Omlyclo, a biosimilar of Novartis's Xolair, has received Canadian approval for chronic urticaria, rhinosinusitis, and allergic asthma ...

South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of ...

South Korean biopharmaceutical firm Celltrion said Monday that it has received approval from Health Canada for Omlyclo, its omalizumab biosimilar referencing Xolair, designed to treat allergic asthma ...

Korea's pharmaceutical giant Celltrion said Monday that it has received approval from Canadian health authorities for a ...

Samsung Electronics on Wednesday replaced its foundry business head in its year-end leadership reshuffle and created the new president-level position of chief technology officer in an apparent ...

South Korean private equity firms (PEF) Corstone Asia and Q Capital Partners plan to sell Norang Tongdak, the Korean-style fried chicken franchise. According to investment banking industry sources on ...

One of the runways at Vancouver International Airport will be closed for several days after a jet carrying Amazon packages overran it Tuesday morning. The Prime Air Boeing 767-300 operated by ...

"Artists have a mission to capture their version of beauty in its purest state, free of all industry expectations and trends. We are protecting and accompanying artists in the process, because it is ...

Celltrion announces acquisition of iQone Healthcare Switzerland, accelerating direct commercialization of its biosimilars in the European region The acquisition strengthens Celltrion’s presence in ...

Representative Kevin Kiley (R-Roseville) announced Wednesday that he plans to introduce a bill to eliminate federal funding for the California High-Speed Rail project. “California’s … ...